explore -WSS

explore

author：knowledge 2025-10-01 01:49:59 - browse：8199

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Investment in vaccine development is lagging, report finds

leisure time

WSS

Addressing health care workers' trauma can help fight burnout

Scrutiny of post

Questions and answers about ramping up H5N1 bird flu vaccine

H5N1 bird flu outbreak: Second human case reported, in Michigan

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

focus

explore

entertainment

In Memoriam: Notable people who died in 2023

Listen: More tumult at BIO & coercive care for sickle cell patients

Medical leaders decry Supreme Court decision on affirmative action

Why you shouldn’t ask, “What country has the best health care?”

New air purifier tech could be key to improving indoor air quality

Boston competes with Raleigh

Affirmative action in medical school literally saved lives

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Cancer drug shortages should be causing more outrage

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

entertainment

Why Medicare shouldn’t cover every FDA

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Making the case for fair compensation in clinical trials

Wegovy leads to weight loss. Can it treat depression, too?

Reports of telehealth's death have been greatly exaggerated

Medicare Advantage insurers face 0.2% cut to 2025 payments

Wikipedia

leisure time

focus

knowledge